Vanessa Kennedy (@vekennedy) 's Twitter Profile
Vanessa Kennedy

@vekennedy

Assistant Professor @StanfordMed | Myeloid Malignancies, Cellular Therapies

ID: 25085867

calendar_today18-03-2009 15:00:28

71 Tweet

303 Followers

376 Following

Ana I. Velázquez Mañana, MD, MSc, FASCO (@anavmanana) 's Twitter Profile Photo

Great work by Anna Parks & mentors summarizing & understanding the rapidly evolving recommendations for #COVID19 coagulopathy and VTE ncbi.nlm.nih.gov/pmc/articles/P… UCSF Helen Diller Family Comprehensive Cancer Ctr @HemoncUcsf ASH #hematology

CNN (@cnn) 's Twitter Profile Photo

“It’s easier to be a parent this morning. It’s easier to be a dad. It’s easier to tell your kids character matters. It matters. Tell them the truth matters." Van Jones reacts after CNN projected Joe Biden as the winner of the presidential election. cnn.it/2Id1pmU

Bita Fakhri (@bitafakhri) 's Twitter Profile Photo

A fantastic write-up of a case of EBV-negative Aggressive NK-cell Leukemia (ANKL) and how genomics helped clarify the diagnosis by ⁦UCSF Helen Diller Family Comprehensive Cancer Ctr⁩ star fellow ⁦Vanessa Kennedy. ⁦Roberto Ruiz-Cordero⁩ ⁦@BobOhgami⁩ ⁦@ncdunavin⁩ clinical-lymphoma-myeloma-leukemia.com/article/S2152-…

Frontiers - Oncology (@frontoncology) 's Twitter Profile Photo

⭐ #2: FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies 👨‍⚕️👩‍⚕️ Vanessa Kennedy & Catherine C. Smith Read here 👉 bit.ly/3dNE33x UCSF Helen Diller Family Comprehensive Cancer Ctr #AMLsm #LEUsm #Leukemia #HemOnc #Oncology #OpenAccess

⭐ #2: FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies

👨‍⚕️👩‍⚕️ <a href="/vekennedy/">Vanessa Kennedy</a> &amp; Catherine C. Smith

Read here 👉 bit.ly/3dNE33x

<a href="/UCSFCancer/">UCSF Helen Diller Family Comprehensive Cancer Ctr</a> #AMLsm #LEUsm #Leukemia #HemOnc #Oncology #OpenAccess
JCO Clinical Cancer Informatics (@jcocci_asco) 's Twitter Profile Photo

🎉👋 Welcome to our new #JCOCCI Editorial Fellows! Benjamin Bates & Vanessa Kennedy will spend the next year getting a peek behind the curtain of JCO CCI, and learning from SanjayAnejaMD and others what it's like to be a journal editor.

🎉👋 Welcome to our new #JCOCCI Editorial Fellows! <a href="/Ben_A_Bates/">Benjamin Bates</a> &amp; <a href="/vekennedy/">Vanessa Kennedy</a> will spend the next year getting a peek behind the curtain of JCO CCI, and learning from <a href="/SanjayAnejaMD/">SanjayAnejaMD</a> and others what it's like to be a journal editor.
Anand Patel (@anand_88_patel) 's Twitter Profile Photo

A very helpful paper in Blood Advances by Vanessa Kennedy et al outlining outcomes in mast cell leukemia #mpnsm #leusm - median OS 1.6 years - midostaurin the most commonly used agent - mutational profile in below image ashpublications.org/bloodadvances/…

A very helpful paper in <a href="/BloodAdvances/">Blood Advances</a> by <a href="/vekennedy/">Vanessa Kennedy</a>  et al outlining outcomes in mast cell leukemia #mpnsm #leusm 
- median OS 1.6 years
- midostaurin the most commonly used agent
- mutational profile in below image
ashpublications.org/bloodadvances/…
Ben Hamner (@benhamner) 's Twitter Profile Photo

Hiring core of ml/data/engineering team for our new co (w/ Anthony Goldbloom). DM if interested Goal: Apply AI to build high quality data repo of world's knowledge. Make this repo delightful to consume through APIs, UIs, DB integrations & intelligent joins to your internal data

Anand Patel (@anand_88_patel) 's Twitter Profile Photo

Please join us on June 2nd at 1pm for the ASCO #ASCO23 oral abstract session on leukemia, MDS & cell therapies! It's an incredible lineup of abstracts covering CAR-T, myeloid malignancies, and ALL! I'm excited to be discussing Abstracts 7003-7005 #leusm #mdssm

Please join us on June 2nd at 1pm for the <a href="/ASCO/">ASCO</a> #ASCO23 oral abstract session on leukemia, MDS &amp; cell therapies! It's an incredible lineup of abstracts covering CAR-T, myeloid malignancies, and ALL! 

I'm excited to be discussing Abstracts 7003-7005 #leusm #mdssm
Transplantation and Cellular Therapy Journal (@astct_journal) 's Twitter Profile Photo

A 10-year study examining #cGVHD durability and immune reconstitution reveals sustained reduction in cGVHD rate and lasting B cell changes post #HCT Rituximab prophylaxis, with altered subset composition and decreased alloantibody formation. Vanessa Kennedy ow.ly/wT2850RxXAs

A 10-year study examining #cGVHD durability and immune reconstitution reveals sustained reduction in cGVHD rate and lasting B cell changes post #HCT Rituximab prophylaxis, with altered subset composition and decreased alloantibody formation. <a href="/vekennedy/">Vanessa Kennedy</a> ow.ly/wT2850RxXAs